In closing and based on what we know today, we are reaffirming our guidance for 2023 net sales of 2.13 to $2,170,000,000 adjusted EBITDA of $310,000,000 to $330,000,000 and adjusted diluted earnings per share of $0.95 to $1.15 As a reminder, our 2022 financials included the benefit of Back to Nature in every quarter of the year, While 2023 will not. We also expect full year fiscal 2023 to include Interest expense of $145,000,000 to $150,000,000 including cash interest expense of $140,000,000 to $145,000,000 depreciation expense of $47,500,000 to $52,500,000 amortization expense of $20,000,000 to to $22,000,000 an effective tax rate of 26.5% to 27.5% and CapEx of $35,000,000 to $40,000,000 to be recorded. Now, I will turn the call back over to Casey for further remarks.